{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:20:24Z","timestamp":1791825624623,"version":"4.3.4"},"reference-count":33,"publisher":"IMR Press","issue":"12","license":[{"start":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T00:00:00Z","timestamp":1640822400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Liver fibrosis is a dysregulated wound-healing process in response to diverse liver injuries, and an effective drug therapy is not yet available. Genistein, which is one of the most active natural flavonoids mainly derived from soybean products (e.g., Cordyceps sinensis mycelium), exhibits various biological effects, including hepatoprotective and anti-inflammatory properties. However, the anti-hepatic fibrosis mechanisms of genistein are poorly understood. The aim of our research is to explore the effect and the possible mechanism of genistein against liver fibrosis. Materials and methods: Cell counting kit-8, EdU, and flow cytometry assays were applied to evaluate the effects of genistein on cell viability, proliferation, and cell cycle arrest in human hepatic stellate cell (HSC) line LX2 cells. HSC activation was induced by transforming growth factor-\u03b21 in LX2 cells and liver fibrosis model was established by the intraperitoneal injection of dimethylnitrosamine (DMN) in rats to assess the anti-fibrosis effects of genistein in vivo and in vitro models. HSC activation was assessed by qRT-PCR, Western blot, immunohistochemistry, and immunofluorescent assay. Liver injury and collagen deposition were evaluated by histopathological assay, serum biochemistry, and hepatic hydroxyproline content assays. The mRNA expressions of matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), and inflammation related-factors were assessed by qRT-PCR assay. Furthermore, the functional properties of macrophage in the liver were assessed by immunohistochemistry assay. The expression levels of the JAK2\/STAT3\/SOCS3 signaling pathway related-protein were assessed by Western blot analysis. Results: Genistein significantly inhibited cell viability and proliferation and induced cell cycle arrest at G0\/G1 phase in LX2 cells, respectively. Furthermore, oral administration of genistein significantly ameliorated liver injury and the collagen deposition in rats with DMN-induced fibrosis model. Genistein suppressed the expression levels of HSC activation marker \u03b1-smooth muscle actin and collagen type I alpha 1 in vivo and in vitro. Genistein significantly decreased the mRNA expression levels of extracellular matrix degradation genes MMP2\/9 and TIMP1 in rats. Genistein alleviated the mRNA expression levels of IL-1\u03b2, IL-6, TNF-\u03b1, and MCP-1 and regulated the protein expressions of CD68, CD163, and CD206 in the liver. Moreover, genistein attenuated the expressions of p-JAK2\/JAK2, p-STAT3\/STAT3, and SOCS3 protein both in vivo and in vitro. Conclusion: Taken together, our results showed that genistein could be improved liver fibrosis both in vivo and in vitro, probably through regulating the functional properties of macrophage and inhibiting the JAK2\/STAT3\/SOCS3 signaling pathway.<\/jats:p>","DOI":"10.52586\/5050","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T20:16:31Z","timestamp":1640895391000},"source":"Crossref","is-referenced-by-count":35,"title":["Hepatoprotective effect of genistein against dimethylnitrosamine-induced liver fibrosis in rats by regulating macrophage functional properties and inhibiting the JAK2\/STAT3\/SOCS3 signaling pathway"],"prefix":"10.31083","volume":"26","author":[{"given":"Ying","family":"Xu","sequence":"first","affiliation":[{"name":"Experiment Center of Teaching & Learning, Institute of Chinese Materia Medica, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"},{"name":"Institute of Liver Diseases, Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingqi","family":"Zhang","sequence":"first","affiliation":[{"name":"Institute of Liver Diseases, Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Yang","sequence":"first","affiliation":[{"name":"Institute of Liver Diseases, Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"first","affiliation":[{"name":"Experiment Center of Teaching & Learning, Institute of Chinese Materia Medica, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"},{"name":"Institute of Liver Diseases, Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linzhang","family":"Zhang","sequence":"first","affiliation":[{"name":"Experiment Center of Teaching & Learning, Institute of Chinese Materia Medica, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"},{"name":"Institute of Liver Diseases, Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Zhang","sequence":"first","affiliation":[{"name":"Institute of Liver Diseases, Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaofeng","family":"Chen","sequence":"first","affiliation":[{"name":"Institute of Liver Diseases, Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Hu","sequence":"first","affiliation":[{"name":"Institute of Liver Diseases, Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Chen","sequence":"first","affiliation":[{"name":"Institute of Liver Diseases, Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"first","affiliation":[{"name":"Institute of Liver Diseases, Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Mu","sequence":"first","affiliation":[{"name":"Institute of Liver Diseases, Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"first","affiliation":[{"name":"Experiment Center of Teaching & Learning, Institute of Chinese Materia Medica, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"},{"name":"Institute of Liver Diseases, Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"first","affiliation":[{"name":"Experiment Center of Teaching & Learning, Institute of Chinese Materia Medica, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"},{"name":"Institute of Liver Diseases, Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2021,12,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014; 383: 1749\u20131761.","DOI":"10.1016\/S0140-6736(14)60121-5"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Friedman SL. Evolving challenges in hepatic fibrosis. Nature Reviews. Gastroenterology & Hepatology. 2010; 7: 425\u2013436.","DOI":"10.1038\/nrgastro.2010.97"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Ellis EL, Mann DA. Clinical evidence for the regression of liver fibrosis. Journal of Hepatology. 2012; 56: 1171\u20131180.","DOI":"10.1016\/j.jhep.2011.09.024"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Schuppan D, Kim YO. Evolving therapies for liver fibrosis. The Journal of Clinical Investigation. 2013; 123: 1887\u20131901.","DOI":"10.1172\/JCI66028"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Zhou C, York SR, Chen JY, Pondick JV, Motola DL, Chung RT, et al. Long noncoding RNAs expressed in human hepatic stellate cells form networks with extracellular matrix proteins. Genome Medicine. 2016; 8: 31.","DOI":"10.1186\/s13073-016-0285-0"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Arthur MJ. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. American Journal of Physiology. Gastrointestinal and Liver Physiology. 2000; 279: G245\u2013G249.","DOI":"10.1152\/ajpgi.2000.279.2.G245"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Chang T, Liaw Y, Wu S, Schiff E, Han K, Lai C, et al. Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology. 2010; 52: 886\u2013893.","DOI":"10.1002\/hep.23785"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Wynn T, Barron L. Macrophages: Master Regulators of Inflammation and Fibrosis. Seminars in Liver Disease. 2010; 30: 245\u2013257.","DOI":"10.1055\/s-0030-1255354"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Tacke F, Zimmermann HW. Macrophage heterogeneity in liver injury and fibrosis. Journal of Hepatology. 2014; 60: 1090\u20131096.","DOI":"10.1016\/j.jhep.2013.12.025"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Li H, You H, Fan X, Jia J. Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets. BMJ Open Gastroenterology. 2016; 3: e000079.","DOI":"10.1136\/bmjgast-2016-000079"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Mohammadi A, Blesso CN, Barreto GE, Banach M, Majeed M, Sahebkar A. Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent. The Journal of Nutritional Biochemistry. 2019; 66: 1\u201316.","DOI":"10.1016\/j.jnutbio.2018.12.005"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Li WX. Canonical and non-canonical JAK-STAT signaling. Trends in Cell Biology. 2008; 18: 545\u2013551.","DOI":"10.1016\/j.tcb.2008.08.008"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Xin P, Xu X, Deng C, Liu S, Wang Y, Zhou X, et al. The role of JAK\/STAT signaling pathway and its inhibitors in diseases. International Immunopharmacology. 2020; 80: 106210.","DOI":"10.1016\/j.intimp.2020.106210"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Kong X, Horiguchi N, Mori M, Gao B. Cytokines and STATs in Liver Fibrosis. Frontiers in Physiology. 2012; 3: 69.","DOI":"10.3389\/fphys.2012.00069"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Lakner AM, Moore CC, Gulledge AA, Schrum LW. Daily genetic pro\ufb01ling indicates JAK\/STAT signaling promotes early hepatic stellate cell transdifferentiation. World Journal of Gastroenterology. 2010; 16: 5047\u20135056.","DOI":"10.3748\/wjg.v16.i40.5047"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Ogata H, Chinen T, Yoshida T, Kinjyo I, Takaesu G, Shiraishi H, et al. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene. 2006; 25: 2520\u20132530.","DOI":"10.1038\/sj.onc.1209281"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Handy JA, Saxena NK, Fu P, Lin S, Mells JE, Gupta NA, et al. Adiponectin activation of AMPK disrupts leptin-mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS-3). Journal of Cellular Biochemistry. 2010; 110: 1195\u20131207.","DOI":"10.1002\/jcb.22634"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"George J, Rao KR, Stern R, Chandrakasan G. Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen. Toxicology. 2001; 156: 129\u2013138.","DOI":"10.1016\/S0300-483X(00)00352-8"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Ohara F, Nii A, Sakiyama Y, Tsuchiya M, Ogawa S. Pathophysiological characteristics of dimethylnitrosamine-induced liver fibrosis in acute and chronic injury models: a possible contribution of KLF5 to fibrogenic responses. Digestive Diseases and Sciences. 2008; 53: 2222\u20132232.","DOI":"10.1007\/s10620-007-0112-y"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Thangavel P, Puga-Olgu\u00edn A, Rodr\u00edguez-Landa JF, Zepeda RC. Genistein as Potential Therapeutic Candidate for Menopausal Symptoms and Other Related Diseases. Molecules. 2019; 24: 3892.","DOI":"10.3390\/molecules24213892"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Li S, Li J, Dai W, Zhang Q, Feng J, Wu L, et al. Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death. British Journal of Cancer. 2017; 117: 1518\u20131528.","DOI":"10.1038\/bjc.2017.323"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Xin X, Chen C, Hu Y, Feng Q. Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD). Biomedicine & Pharmacotherapy. 2019; 117: 109047.","DOI":"10.1016\/j.biopha.2019.109047"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Li X, Peng J, Sun Z, Tian H, Duan X, Liu L, et al. Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2\/9, TIMP1\/2 and the TGF-\u03b2\/Smad signaling pathways. Acta Pharmacologica Sinica. 2016; 37: 783\u2013793.","DOI":"10.1038\/aps.2016.35"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Hemmann S, Graf J, Roderfeld M, Roeb E. Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies. Journal of Hepatology. 2007; 46: 955\u2013975.","DOI":"10.1016\/j.jhep.2007.02.003"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Ganai AA, Husain M. Genistein attenuates D-GalN induced liver fibrosis\/chronic liver damage in rats by blocking the TGF-\u03b2\/Smad signaling pathways. Chemico-Biological Interactions. 2017; 261: 80\u201385.","DOI":"10.1016\/j.cbi.2016.11.022"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Salas AL, Montezuma TD, Fari\u00f1a GG, Reyes-Esparza J, Rodr\u00edguez-Fragoso L. Genistein modifies liver fibrosis and improves liver function by inducing uPA expression and proteolytic activity in CCl4-treated rats. Pharmacology. 2008; 81: 41\u201349.","DOI":"10.1159\/000107968"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Wan C, Jin F, Du Y, Yang K, Yao L, Mei Z, et al. Genistein improves schistosomiasis liver granuloma and fibrosis via dampening NF-\u03baB signaling in mice. Parasitology Research. 2017; 116: 1165\u20131174.","DOI":"10.1007\/s00436-017-5392-3"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Yoo N, Jeon S, Nam Y, Park Y, Won SB, Kwon YH. Dietary Supplementation of Genistein Alleviates Liver Inflammation and Fibrosis Mediated by a Methionine-Choline-Deficient Diet in db\/db Mice. Journal of Agricultural and Food Chemistry. 2015; 63: 4305\u20134311.","DOI":"10.1021\/acs.jafc.5b00398"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Li X, Peng J, Sun Z, Tian H, Duan X, Liu L, et al. Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2\/9, TIMP1\/2 and the TGF-\u03b2\/Smad signaling pathways. Acta Pharmacologica Sinica. 2016; 37: 783\u2013793.","DOI":"10.1038\/aps.2016.35"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Zhang D, Zhang L, Chen G, Xu Y, Yang H, Xiao Z, et al. Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells. Pharmaceutical Biology. 2020; 58: 1229\u20131243.","DOI":"10.1080\/13880209.2020.1855212"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nature Reviews Immunology. 2014; 14: 181\u2013194.","DOI":"10.1038\/nri3623"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Fu YD, Xiao Z, Tian XT, Liu W, Hu YH, Fang J, et al. The Novel Chinese Medicine JY5 Formula Alleviates Hepatic Fibrosis by Inhibiting the Notch Signaling Pathway. Frontiers in Pharmacology. 2021; 12: 671152.","DOI":"10.3389\/fphar.2021.671152"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Bai L, Fu L, Li L, Ren F, Zheng Q, Liu S, et al. Cellular mechanisms of Hepatoprotection Mediated by M2-like Macrophages. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2018; 24: 2675\u20132682.","DOI":"10.12659\/MSM.907222"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/26\/12\/10.52586\/5050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T06:40:56Z","timestamp":1732689656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/26\/12\/10.52586\/5050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,30]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"alternative-id":["S2768-6701(21)00321-X"],"URL":"https:\/\/doi.org\/10.52586\/5050","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,30]]},"article-number":"1572"}}